Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenRegular treatment with formoterol for chronic asthma: serious adverse eventsAddition to inhaled corticosteroids of long-acting beta 2-agonists versus anti-leukotrienes for chronic asthmaAddition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaPatient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment optionsRetrospective observations on the ability to diagnose and manage patients with asthma through the use of impulse oscillometry: comparison with spirometry and overview of the literature.Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.Modulite technology in the development of formoterol HFA pMDI: clinical evidence and future opportunities.Noninferiority studies with multiple reference treatments.Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.Pharmacokinetics of budesonide and formoterol administered via a series of single-drug and combination inhalers: four open-label, randomized, crossover studies in healthy adults.
P2860
Q24197682-5B0FEB67-32F2-47F6-8EA5-6105C9FBF070Q24200353-BF8D0454-AFFA-4B6D-975A-D95FA6AA012FQ24200999-797AE353-456D-40DD-90BF-7ADFF0D7CA0EQ24234499-18BE9DF9-17CB-46DA-BE10-4BF825CFEED6Q24244152-33944D7A-4D7C-4101-896D-7D5F6086C158Q33644839-ED80CD71-31D6-4242-A499-EC3171BDF63AQ38199097-B3661618-575D-4DF5-831C-C1CC4240A4F4Q38909886-49966B19-0D98-4E36-8C88-0ADCA1710E9DQ40129417-B4624D7B-DFB3-4FAA-9158-15B95749F427Q41189857-9EB1403D-7414-4AB8-80AA-D752A30A46A5Q44076747-23AAB643-6F49-4559-886D-97873658DF49Q46486322-65402048-6B4C-4C22-B833-3413764423E9
P2860
Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@ast
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@en
type
label
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@ast
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@en
prefLabel
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@ast
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@en
P2093
P2860
P1476
Comparison of bronchoprotectiv ...... bo-controlled, crossover study
@en
P2093
A P Monici Preti
C M Houghton
S J Langley
P2860
P304
P356
10.1111/J.1365-2125.2004.02172.X
P407
P577
2004-10-01T00:00:00Z